| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.11 | 0.08 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.08 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.08 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |